VWA
JAZZ icon

Valued Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Valued Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.4K Buy
18
+15
+500% +$2.62K ﹤0.01% 459
2025
Q4 		$510 Buy
3
+1
+50% +$153 ﹤0.01% 533
2025
Q3 		$264 Hold
2
– – ﹤0.01% 560
2025
Q2 		$213 Hold
2
– – ﹤0.01% 572
2025
Q1 		$249 Hold
2
– – ﹤0.01% 597
2024
Q4 		$247 Hold
2
– – ﹤0.01% 602
2024
Q3 		$223 Hold
2
– – ﹤0.01% 591
2024
Q2 		$214 Sell
2
-16
-89% -$1.76K ﹤0.01% 558
2024
Q1 		$2.17K Buy
18
+15
+500% +$1.84K ﹤0.01% 348
2023
Q4 		$389 Buy
+3
New +$374 ﹤0.01% 456

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Valued Wealth Advisors's JAZZ Position: Q1 2026 in Review

Valued Wealth Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 500% in Q1 2026, buying an estimated $2.62K and bringing the position to 18 shares worth $3.4K. The position accounts for ﹤0.01% of the portfolio, ranked #459.

Valued Wealth Advisors first reported a position in JAZZ in Q4 2023 and has held it in 10 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Valued Wealth Advisors held 18 shares of Jazz Pharmaceuticals worth $3.4K as of Q1 2026.
  • Valued Wealth Advisors bought 15 Jazz Pharmaceuticals shares in Q1 2026, an estimated $2.62K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Valued Wealth Advisors's portfolio in Q1 2026, its #459 holding.
  • Valued Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Valued Wealth Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.